IADR & GSK announce 2005 Innovation in Oral Care Awards
Alexandria, Virginia…The International Association for Dental Research and GlaxoSmithKline Consumer Healthcare today announced the winners of the IADR/GSK Innovation in Oral Care Awards for 2005. These awards are intended to inspire innovative and novel research in oral care with a direct impact on the quality of human life.
A large number of applications was received from teams of researchers around the globe, and these were reviewed by an internationally recognized panel of experts, under the chairmanship of Dr. John Stamm, former Dean, University of North Carolina at Chapel Hill School of Dentistry.
The awards, to be provided in the form of an unrestricted research grant, will be funded by GSK and administered by the IADR. The three teams to receive funding will share $225,000 and include three academic centers:
University of California-San Francisco, USA (Dr. John Featherstone and co-workers) University of Iceland, Reykjavik (Dr. Peter Holbrook and co-workers) University of Illinois at Chicago, USA (Dr. Lin Tao and co-workers)
The awards will be formally presented during the 83rd General Session of IADR/AADR, to be held in Baltimore, Maryland, March 9-12, 2005.
"The IADR is delighted to be partnered with GSK in delivering the Innovation in Oral Care Awards," noted Professor Paul Robertson, IADR President and Dean Emeritus of the University of Washington School of Dentistry. "This is the second year of the IADR/GSK Oral Care Awards and we are encouraged by a large number of high quality proposals submitted for improving the oral health of the public. We look forward to a continuing partnership with GlaxoSmithKline in the years to come."
"GSK is privileged to work with the IADR and to make these funds available to such talented teams of researchers. All three winning entries addressed very significant but different quality-of-life issues and GlaxoSmithKline hopes that these innovative concepts will one day be widely available to those suffering from oral diseases which today are not easily prevented or treated," said Dr. David Alexander, Director of Worldwide Professional Affairs for GlaxoSmithKline Consumer Healthcare. "We have been extremely pleased with the progress of the projects funded from last year and look forward to the progress of these new awards from such innovative scientists and clinicians among IADR's global membership."
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.